Loading organizations...
NovaQuest Capital Management operates as a specialized life science investment firm focused on the biopharmaceutical sector. The firm provides capital through product finance structures to support the late-stage development of life-saving drugs and innovative biopharmaceutical products. This financial model is designed to facilitate the progression of critical healthcare solutions, aiming to bring new treatments to market more efficiently.
Information regarding the company's founders, precise founding year, and the specific originating insight is not readily available within the provided search snippets. A deeper exploration into the firm’s history would typically reveal these foundational details and the strategic rationale that led to its establishment as a dedicated biopharmaceutical investor.
NovaQuest serves partners within the global biopharmaceutical industry, as well as the animal health sector, by funding product development initiatives. The firm’s vision centers on fostering innovation that leads to improved patient outcomes and a healthier, more productive society. It ultimately aims to contribute to reducing overall healthcare costs through strategic investments in product development.
Key people at NovaQuest Capital Management.
NovaQuest Capital Management was founded in 2010 by Ron Wooten (Founder & Managing Partner).
NovaQuest Capital Management was founded in 2010 by Ron Wooten (Founder & Managing Partner).
Key people at NovaQuest Capital Management.
NovaQuest Capital Management has 5 tracked investments across 3 companies. The latest tracked deal is $180.0M Series A in Arvelle Therapeutics in February 2019.